The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Amifostine: The First Selective-Target and Broad-Spectrum Radioprotector
Open accessAbstract
Learning Objectives: After completing this course, the reader will be able to: Select appropriate multidisciplinary treatment regimens and cytoprotection for clinical trials for patients with head and neck cancer.Identify radiation toxicity for the head and neck, lung, and pelvic irradiated areas.Describe the cytoprotective effect of amifostine against radiation toxicity. CME Access and take the CME test online and receive 1 AMA PRA Category 1 Credit™ at CME.TheOncologist.com
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1968) · American Association of Industrial Nurses Journal · doi:10.1177/216507996801601208 · Cited by 8,798
Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis
Carmeliet, P., Dor, Y., Herbert, J.-M., Fukumura, D., Brusselmans, K., Dewerchin, M., Neeman, M., Bono, F., Abramovitch, R., Maxwell, P., et al. (1998) · Nature · doi:10.1038/28867 · Cited by 2,502
Kajstura, J., Cheng, W. N., Krzysztof Reiss, F., CLARK, W. A., Sonnenblick, E. H., Krajewski, S., Reed, J., Olivetti, G., & Anversa, P. (1996) · PubMed · Cited by 1,039
Effects of radiation on normal tissue: consequences and mechanisms
Stone, H. B., Coleman, C. N., Anscher, M. S., & McBride, W. H. (2003) · The Lancet Oncology · doi:10.1016/s1470-2045(03)01191-4 · Cited by 931
Eisbruch, A., Ten Haken, R. K., Kim, H. M., Marsh, L. H., & Ship, J. A. (1999) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(99)00247-3 · Cited by 922
Phase III Randomized Trial of Amifostine as a Radioprotector in Head and Neck Cancer
Brizel, D. M., Wasserman, T. H., Henke, M., Strnad, V., Rudat, V., Monnier, A., Eschwege, F., Zhang, J., Russell, L., Oster, W., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.19.3339 · Cited by 828
Shimizu, S., Eguchi, Y., Kamiike, W., Itoh, Y., Hasegawa, J., Yamabe, K., Otsuki, Y., Matsuda, H., & Tsujimoto, Y. (1996) · PubMed · Cited by 361
Hensley, M. L., Schuchter, L., Lindley, C., Meropol, N., Cohen, G., Broder, G., Gradishar, W., Green, D., Langdon, R., Mitchell, R. B., et al. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.10.3333 · Cited by 335
Yuhas, J. M. (1980) · PubMed · Cited by 294
The role of WR-2721 in radiotherapy and/or chemotherapy.
Yuhas, J. M., Spellman, J. M., & Čulo, F. (1980) · PubMed · Cited by 281
Cited by
Machtay, M., Moughan, J., Trotti, A., Garden, A. S., Weber, R. S., Cooper, J. S., Forastiere, A., & Ang, K. K. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.8841 · Cited by 1,371
Thorough Study of Reactivity of Various Compound Classes toward the Folin−Ciocalteu Reagent
Everette, J. D., Bryant, Q. M., Green, A. M., Abbey, Y. A., Wangila, G. W., & Walker, R. B. (2010) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf1005935 · Cited by 923
Roca, F. J., & Ramakrishnan, L. (2013) · Cell · doi:10.1016/j.cell.2013.03.022 · Cited by 592
Radioprotectors and mitigators of radiation-induced normal tissue injury
Citrin, D., Cotrim, A. P., Hyodo, F., Baum, B. J., Krishna, M. C., & Mitchell, J. B. (2010) · The Oncologist · doi:10.1634/theoncologist.2009-s104 · Cited by 482
Strategies for optimizing the response of cancer and normal tissues to radiation
Moding, E. J., Kastan, M. B., & Kirsch, D. G. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4003 · Cited by 461
Metadata
- Authors
- Kouvaris, J. R., Kouloulias, V. E., & Vlahos, L. J.
- Venue
- The Oncologist
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-06-01
- Volume
- 12
- Issue
- 6
- Pages
- 738-747
- ISSN
- 1083-7159 (ISSN-L)
- 1549-490X
- OpenAlex
- W2111651157
- Cited by
- 456
- References
- 33
- FWCI
- 9.80
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Amifostine: The First Selective-Target and Broad-Spectrum Radioprotector. https://app.cochat.ai/papers/10.1634/theoncologist.12-6-738
- The paper
- Kouvaris, J. R., Kouloulias, V. E., & Vlahos, L. J. (2007). Amifostine: The First Selective-Target and Broad-Spectrum Radioprotector. The Oncologist. https://doi.org/10.1634/theoncologist.12-6-738
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.